EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ATP8B1 Deficiency Causes Phosphodiesterase 4‐Mediated Glucagon Resistance and Impaired Gluconeogenesis in Mouse and Human Liver

Jung-Chin Chang, Wietse In Het Panhuis iD, Shu-Hao Hsu, Suzanne Duijst, Kam S Ho-Mok, Jolie F van der Heiden iD, Zhixiong Ying, Joris I Erdmann, Georg F Vogel iD, Norman Junge iD, Björn Hartleben, Pim J Koelink und 7 weitere

Liver International · 2025

DOI: 10.1111/liv.70306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Jung-Chin Chang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Gluconeogenesis, Liver, Glucagon, Cyclic Nucleotide Phosphodiesterases, Type 4. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Deficiency of the phospholipid transporter ATP8B1 causes infantile‐onset progressive familial intrahepatic cholestasis type I (PFIC1). Pre‐transplant PFIC1 patients often present with mild dyslipidaemia. This raises the possibility that PFIC1 patients, besides cholestasis, may also experience defects in glucose and lipid metabolism. In this study, we aimed to investigate the role of ATP8B1 in hepatic glucose and lipid metabolism using the Atp8b1 G308V/G308V mutant mouse, a pre‐clinical model of PFIC1.

Methods

Atp8b1 G308V/G308V and wild‐type mice on normal chow were examined. Hepatic glucose metabolism was evaluated by oral glucose tolerance testing, quantification of fasting plasma glucose, insulin and lipids. Mechanistic studies were conducted in primary mouse hepatocytes (PMHs) and HepG2 cells overexpressing glucagon receptor (HepG2‐GCGR). The findings in the mouse model were validated in pre‐transplant livers from PFIC1 patients.

Results

Atp8b1 G308V/G308V mice showed decreased levels of fasting blood glucose, triglycerides and insulin, indicating normal insulin sensitivity and impaired hepatic glucagon response. PMHs from Atp8b1 G308V/G308V mice exhibited reduced glucagon‐dependent cAMP levels and signalling and had increased expression of Pde4 isoforms. Rolipram‐mediated PDE4 inhibition restored glucagon signalling. ATP8B1 knockdown HepG2‐GCGR cells also showed increased PDE4D expression and impaired glucagon signalling. Liver tissue from PFIC1 patients exhibited elevated PDE4D and reduced p‐CREB levels and very low glycogen content.

Conclusions

ATP8B1 deficiency causes upregulation of PDE4D in the liver of Atp8b1 G308V/G308V mice and PFIC1 patients. PDE4D‐mediated glucagon resistance impairs gluconeogenesis and stimulates compensatory glycogenolysis in Atp8b1 G308V/G308V mice and PFIC1 patients. Our study reveals novel metabolic insights of ATP8B1 deficiency in PFIC1 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GluconeogenesisLiverGlucagonCyclic Nucleotide Phosphodiesterases, Type 4Cholestasis, IntrahepaticAdenosine TriphosphatasesAnimalsHumansMiceDisease Models, AnimalHepatocytesHep G2 CellsMaleBlood GlucoseInsulin

Stichwörter der Autor:innen

cholestasiscyclic adenosine monophosphategluconeogenesisglucose

Substanzen

GlucagonCyclic Nucleotide Phosphodiesterases, Type 4ATP8B1 protein, humanAdenosine TriphosphatasesBlood GlucoseInsulin

Autor:innen und Institutionen

  • Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
  • Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Graduate Institute of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.

ORCID-Profile: Wietse In Het Panhuis, Jolie F van der Heiden, Georg F Vogel, Norman Junge, Weng Chuan Peng, Ronald P J Oude Elferink, Huey-Ling Chen, Stan F J van de Graaf, Coen C Paulusma

Zitieren

APA

Chang, J. C., Panhuis, W. I. H., Hsu, S. H., Duijst, S., Ho-Mok, K. S., van der Heiden, J. F., Ying, Z., Erdmann, J. I., Vogel, G. F., Junge, N., Hartleben, B., Koelink, P. J., van Dijk, S. G., Peng, W. C., Verhoeven, A. J., Oude Elferink, R. P. J., Chen, H. L., van de Graaf, S. F. J., & Paulusma, C. C. (2025). ATP8B1 Deficiency Causes Phosphodiesterase 4‐Mediated Glucagon Resistance and Impaired Gluconeogenesis in Mouse and Human Liver. Liver International. https://doi.org/10.1111/liv.70306

Vancouver

Chang JC, Panhuis WIH, Hsu SH, Duijst S, Ho-Mok KS, van der Heiden JF, et al. ATP8B1 Deficiency Causes Phosphodiesterase 4‐Mediated Glucagon Resistance and Impaired Gluconeogenesis in Mouse and Human Liver. Liver International. 2025. doi:10.1111/liv.70306

BibTeX
@article{Chang2025,
  author = {Chang, Jung-Chin and Panhuis, Wietse In Het and Hsu, Shu-Hao and Duijst, Suzanne and Ho-Mok, Kam S and van der Heiden, Jolie F and Ying, Zhixiong and Erdmann, Joris I and Vogel, Georg F and Junge, Norman and Hartleben, Björn and Koelink, Pim J and van Dijk, Sebastian G and Peng, Weng Chuan and Verhoeven, Arthur J and Oude Elferink, Ronald P J and Chen, Huey-Ling and van de Graaf, Stan F J and Paulusma, Coen C},
  title = {ATP8B1 Deficiency Causes Phosphodiesterase 4‐Mediated Glucagon Resistance and Impaired Gluconeogenesis in Mouse and Human Liver},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70306}
}
Kostenlos starten →